Welcome to our dedicated page for Regency Centers Corporation news (Ticker: $REG), a resource for investors and traders seeking the latest updates and insights on Regency Centers Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Regency Centers Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Regency Centers Corporation's position in the market.
Regency Centers reported its first quarter 2024 results, showing Net Income Attributable to Common Shareholders of $0.58 per diluted share, Nareit FFO of $1.08 per diluted share, and Core Operating Earnings of $1.04 per diluted share. The company increased Same Property NOI by 2.1% year-over-year and saw record high leasing percentages. Regency initiated $80 million in new development projects, received a credit rating upgrade, and completed property dispositions. The company declared a quarterly cash dividend and provided updated 2024 guidance.